Chwan-Fwu Lin

Chwan-Fwu Lin

Auto-generated profile, based on publicly available information

Chwan-Fwu Lin


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2014 in Viruses
Verified
Journal Article
Open access
PDF file
JHJin-Yuan Ho
Jin-Yuan Ho
HCHui-Wen Chang
Hui-Wen Chang
CLChwan-Fwu Lin
Chwan-Fwu Lin
CLChien-Jou Liu
Chien-Jou Liu
CHChung-Fan Hsieh
Chung-Fan Hsieh
JHJim-Tong Horng
Jim-Tong Horng
Bai Shao (BS, the root of Paeonia lactiflora Pall.), a common Chinese herb in many recipes used to treat viral infection and liver diseases, is recognized for its ability to nourish menstruation, its Yin convergence, and as an antiperspirant. However, the mechanism and components for its antiviral function remain to be elucidated. In this study, an ethanolic extract of BS was further partitioned into aqueous and organic parts (EAex) for in vitro functional study and in vivo efficacy testing. EAex exhibited an IC50 of 0.016 ± 0.005 mg/mL against influenza virus A/WSN/33 (H1N1), with broad-spectrum inhibitory activity against different strains of human influenza A viruses, including clinical oseltamivir-resistant isolates and an H1N1pdm strain. The synthesis of both viral RNA and protein was profoundly inhibited when the cells were treated with EAex. A time-of-addition assay demonstrated that EAex exerted its antiviral activity at various stages of the virus replication cycle. We addressed its antiviral activity at virus entry and demonstrated that EAex inhibits viral hemagglutination and viral binding to and penetration into host cells. In vivo animal testing showed that 200 mg/kg/d of EAex offered significant protection against viral infection. We conclude that BS possesses antiviral activity and has the potential for development as an anti-influenza agent.

26 February 2013 in Molecules
Verified
Journal Article
Open access
PDF file
CLChwan-Fwu Lin
Chwan-Fwu Lin
THTsong-Long Hwang
Tsong-Long Hwang
CCChun-Chien Chien
Chun-Chien Chien
HTHuei-Yu Tu
Huei-Yu Tu
HLHorng-Liang Lay
Horng-Liang Lay
A new hydroxychavicol dimer, 2-(g'-hydroxychavicol)-hydroxychavicol (1), was isolated from the roots of Piper betle Linn. along with five known compounds, hydroxychavicol (2), aristololactam A II (3), aristololactam B II (4), piperolactam A (5) and cepharadione A (6). The structures of these isolated compounds were elucidated by spectroscopic methods. Compounds 1 and 2 exhibited inhibitory effects on the generation of superoxide anion and the release of elastase by human neutrophils.

3 June 2013 in Molecules
Verified
Journal Article
Open access
PDF file
SYShun-Chin Yang
Shun-Chin Yang
CLChwan-Fwu Lin
Chwan-Fwu Lin
WCWen-Yi Chang
Wen-Yi Chang
JKJimmy Kuo
Jimmy Kuo
YHYin-Ting Huang
Yin-Ting Huang
THTsong-Long Hwang
Tsong-Long Hwang
It is well known that overwhelming neutrophil activation is closely related to acute and chronic inflammatory injuries. Formyl peptide receptor 1 (FPR1) plays an important role in activation of neutrophils and may represent a potent therapeutic target in inflammatory diseases. In the present study, we demonstrated that IA-LBI07-1 (IA), an extract of bioactive secondary metabolites from a marine Bacillus sp., has anti-inflammatory effects in human neutrophils. IA significantly inhibited superoxide generation and elastase release in formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP)-activated neutrophils, but failed to suppress the cell responses activated by non-FPR1 agonists. IA did not alter superoxide production and elastase activity in cell-free systems. IA also attenuated the downstream signaling from FPR1, such as the Ca2+, MAP kinases and AKT pathways. In addition, IA inhibited the binding of N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys-fluorescein, a fluorescent analogue of FMLP, to FPR1 in human neutrophils and FPR1-transfected HEK293 cells. Taken together, these results show that the anti-inflammatory effects of IA in human neutrophils are through the inhibition of FPR1. Also, our data suggest that IA may have therapeutic potential to decrease tissue damage induced by human neutrophils.